Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:850-857
Published online before print January 25, 2007, doi: 10.1161/01.ATV.0000258809.47285.07
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
27/4/850    most recent
01.ATV.0000258809.47285.07v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Torzewski, M.
Right arrow Articles by Lackner, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Torzewski, M.
Right arrow Articles by Lackner, K. J.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:850.)
© 2007 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Deficiency of Glutathione Peroxidase-1 Accelerates the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice

Michael Torzewski; Viola Ochsenhirt; Andrei L. Kleschyov; Matthias Oelze; Andreas Daiber; Huige Li; Heidi Rossmann; Sotirios Tsimikas; Kurt Reifenberg; Fei Cheng; Hans-Anton Lehr; Stefan Blankenberg; Ulrich Förstermann; Thomas Münzel; Karl J. Lackner

From the Institute of Clinical Chemistry and Laboratory Medicine (M.T., V.O., F.C., H.R., K.J.L.), Department of Medicine II (A.L.K., M.O., A.D., S.B., T.M.), Department of Pharmacology (H.L., U.F.), Central Laboratory Animal Facility (K.R.), Johannes Gutenberg University, Mainz, Germany; Division of Cardiology (S.T), University of California, San Diego, Calif; Institute Universitaire de Pathologie (H-A.L.), Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.

Correspondence to Michael Torzewski, MD, or to Karl J. Lackner, MD, Institute of Clinical Chemistry and Laboratory Medicine, Johannes Gutenberg University, 55101 Mainz, Germany. E-mail torzewski{at}zentrallabor.klinik.uni-mainz.de or lackner@zentrallabor.klinik.uni-mainz.de

Background— We have recently demonstrated that activity of red blood cell glutathione peroxidase-1 is inversely associated with the risk of cardiovascular events in patients with coronary artery disease. The present study analyzed the effect of glutathione peroxidase-1 deficiency on atherogenesis in the apolipoprotein E-deficient mouse.

Methods and Results— Female apolipoprotein E-deficient mice with and without glutathione peroxidase-1 deficiency were placed on a Western-type diet for another 6, 12, or 24 weeks. After 24 weeks on Western-type diet, double-knockout mice (GPx-1–/–ApoE–/–) developed significantly more atherosclerosis than control apolipoprotein E-deficient mice. Moreover, glutathione peroxidase-1 deficiency led to modified atherosclerotic lesions with increased cellularity. Functional experiments revealed that glutathione peroxidase-1 deficiency leads to increased reactive oxygen species concentration in the aortic wall as well as increased overall oxidative stress. Peritoneal macrophages from double-knockout mice showed increased in vitro proliferation in response to macrophage-colony-stimulating factor. Also, we found lower levels of bioactive nitric oxide as well as increased tyrosine nitration as a marker of peroxynitrite production.

Conclusions— Deficiency of an antioxidative enzyme accelerates and modifies atherosclerotic lesion progression in apolipoprotein E-deficient mice.

The present study analyzed the effect of glutathione peroxidase-1 (GPx-1) deficiency on atherogenesis in the apolipoprotein E-deficient mouse (ApoE–/–) on the C57BL/6J background. Our data demonstrate that deficiency of an antioxidative enzyme accelerates and modifies atherosclerotic lesion progression in ApoE–/– mice.


Key Words: antioxidants • atherosclerosis • nitric oxide




This article has been cited by other articles:


Home page
Eur Heart JHome page
S. Tsimikas, J. Willeit, M. Knoflach, M. Mayr, G. Egger, M. Notdurfter, J. L. Witztum, C. J. Wiedermann, Q. Xu, and S. Kiechl
Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study
Eur. Heart J., January 1, 2009; 30(1): 107 - 115.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Chrissobolis, S. P. Didion, D. A. Kinzenbaw, L. I. Schrader, S. Dayal, S. R. Lentz, and F. M. Faraci
Glutathione Peroxidase-1 Plays a Major Role in Protecting Against Angiotensin II-Induced Vascular Dysfunction
Hypertension, April 1, 2008; 51(4): 872 - 877.
[Abstract] [Full Text] [PDF]